In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer.

Hui WangCaiyun NieWeifeng XuJing LiHe GouHuifang LvBeibei ChenJianzheng WangYingjun LiuYunduan HeJing ZhaoXiao-Bing Chen

Published in: Therapeutic advances in gastroenterology (2024)

This study is a retrospective study, which does not require clinical registration.

Keyphrases